Chimeric Therapeutics Ltd CHMMF
$0.00
Last Updated: Sep 06, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CHMMF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Chimeric Therapeutics Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Chimeric Therapeutics Ltd. Stock Analysis CHMMF
United States Health Care Nano Cap Chimeric Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. The company is also building a Cell therapy portfolio.
Chimeric Therapeutics Ltd (CHMMF) Chart
Financial Metrics & Statements of Chimeric Therapeutics Ltd (CHMMF)
FAQ's for Chimeric Therapeutics Ltd (CHMMF)
- As of August 2026, Chimeric Therapeutics Ltd CHMMF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Chimeric Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Chimeric Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Chimeric Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Chimeric Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Chimeric Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Chimeric Therapeutics Ltd (CHMMF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
